The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Timing of hormone therapy and dementia: The critical window theory revisited
Open accessAbstract
Objective: Although previous research has shown that initiation of postmenopausal estrogen hormone therapy (HT) in late life increases risk of dementia, animal studies and some observational studies have suggested that midlife use of HT may be beneficial; however, this has not been rigorously investigated in large population‐based studies. Our objective was to compare HT use in midlife with that in late life on risk of dementia among 5,504 postmenopausal female members of an integrated healthcare delivery system. Methods: HT use was determined at midlife (mean age, 48.7 years) from a survey in 1964 and in late life (mean age, 76 years) using pharmacy databases from 1994 to 1998. Risk of dementia diagnosis was evaluated with inpatient and outpatient diagnoses made in Neurology, Neuropsychology, and Internal Medicine from 1999 to 2008. Cox proportional hazard models were used to examine effects of HT use at different times on dementia risk with adjustment for age, education, race, body mass index, number of children, and comorbidities. Results: A total of 1,524 women (27%) were diagnosed with dementia during the follow‐up period. Compared to women never on HT, those taking HT only at midlife had a 26% decreased risk (multivariate adjusted hazards ratio [aHR], 0.74; 95% confidence interval [CI], 0.58–0.94 ), whereas those taking HT only in late life had a 48% increased risk (aHR, 1.48; 95% CI, 1.10–1.98), and women taking HT at both mid and late life had a similar risk of dementia (aHR, 1.02; 95% CI, 0.78–1.34 ). Interpretation: These findings suggest that use of HT in midlife only may protect against cognitive impairment, whereas HT initiation in late life could have deleterious effects. ANN NEUROL, 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Krieger, N. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.5.703 · Cited by 1,654
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study
Whitmer, R. A., Gunderson, E. P., Barrett-Connor, E., Quesenberry, C. P., & Yaffe, K. (2005) · BMJ · doi:10.1136/bmj.38446.466238.e0 · Cited by 1,090
Self-citationEstrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
Yaffe, K., Sawaya, G., Lieberburg, I., & Grady, D. (1998) · JAMA · doi:10.1001/jama.279.9.688 · Cited by 941
Self-citationZandi, P. P. (2002) · JAMA · doi:10.1001/jama.288.17.2123 · Cited by 906
Karter, A. J., Ackerson, L. M., Darbinian, J. A., D’Agostino, R. B., Ferrara, A., Liu, J., & Selby, J. V. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00742-2 · Cited by 595
Ovarian steroids and the brain: Implications for cognition and aging
McEwen, B. S., Alves, S. E., Bulloch, K., & Weiland, N. G. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_7.8s · Cited by 482
Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population
Selby, J. V., Ray, G. T., Zhang, D., & Colby, C. J. (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1396 · Cited by 344
Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
Resnick, S. M., Maki, P. M., Rapp, S. R., Espeland, M. A., Brunner, R., Coker, L. H., Granek, I. A., Hogan, P., Ockene, J. K., & Shumaker, S. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2097 · Cited by 310
Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age
Henderson, V. W. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.024927 · Cited by 264
Grady, D., Yaffe, K., Kristof, M., Lin, F., Richards, C., & Barrett-Connor, E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01270-6 · Cited by 222
Self-citationZandi, P. P., Carlson, M. C., Plassman, B. L., Welch-Bohmer, K. A., Mayer, L. S., Steffens, D. C., & Breitner, J. C. S. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000055761.75837.23 · Cited by 196
Estrogen and memory in women: how can we reconcile the findings?
Sherwin, B. B. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.12.002 · Cited by 164
The Critical Period Hypothesis: Can It Explain Discrepancies in the Oestrogen‐Cognition Literature?
Sherwin, B. B. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01508.x · Cited by 132
Gibbs, R. B. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb55792.x · Cited by 130
McEwen, B. S., Gould, E., Orchinik, M., Weiland, N. G., & Woolley, C. S. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514757.ch4 · Cited by 128
Automated Multiphasic Screening and Diagnosis
Collen, M. F., Rubin, L., Neyman, J., Dantzig, G. B., Baer, R. M., & SIEGELAUB, A. B. (1964) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.54.5.741 · Cited by 116
Effects of Hormone Replacement Therapy on Cognitive and Brain Aging
Resnick, S. M., & Maki, P. M. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb04023.x · Cited by 110
Selby, J. V., Karter, A. J., Ackerson, L., Ferrara, A. M., & Liu, J. Y. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1547 · Cited by 95
Determinants of Long-term Hormone Replacement Therapy and Reasons for Early Discontinuation
den Tonkelaar, I., & ODDENS, B. J. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00586-4 · Cited by 53
Bernardi, F., Pluchino, N., Stomati, M., Pieri, M., & Genazzani, A. R. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.041 · Cited by 52
Incidence of Dementia in Long-term Hormone Users
Petitti, D. B., Crooks, V. C., Chiu, V. Y., Buckwalter, J. G., & Chui, H. C. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm362 · Cited by 29
Estrogen Therapy and the Brain
Henderson, V. W. (2000) · Elsevier eBooks · doi:10.1016/b978-012453790-3/50022-6 · Cited by 1
Cited by
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021
The 2017 hormone therapy position statement of The North American Menopause Society
(2017) · Menopause · doi:10.1097/gme.0000000000000921 · Cited by 1,001
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Dementia and Cognitive Impairment
Hugo, J., & Ganguli, M. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.04.001 · Cited by 902
Metadata
- Authors
- Whitmer, R. A., Quesenberry, C. P., Zhou, J., & Yaffe, K.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2010-11-12
- Volume
- 69
- Issue
- 1
- Pages
- 163-169
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2048182526
- Cited by
- 259
- References
- 24
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.